Walleye Trading LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2023$566,258
-21.6%
6,843
-38.3%
0.00%
-50.0%
Q2 2022$722,000
+6.2%
11,084
-13.5%
0.00%0.0%
Q4 2021$680,000
-65.8%
12,816
-54.5%
0.00%
-71.4%
Q3 2021$1,989,000
-0.2%
28,183
-5.7%
0.01%
-12.5%
Q2 2021$1,992,000
+7014.3%
29,902
+4171.7%
0.01%
Q4 2016$28,000
+100.0%
700
+75.0%
0.00%
Q3 2016$14,000
+16.7%
400
+33.3%
0.00%
Q2 2015$12,0003000.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders